Obetix is the only choice for Primary Biliary Cirrhosis (PBC) with the combination of UDCA (Ursodeoxycholic Acid)
Obeticholic Acid is indicated for the treatment of primary biliary cholangitis (PBC) in combination with Ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA. This indication is approved under accelerated approval based on a reduction in alkaline phosphatase (ALP).
Product Name : Obetix 5
Generic Name : Obeticholic Acid
Formulation : Tablet
Available Pack Size : 30’s Pot
Available Strengths : 5 mg
Categories : Anti-viral, Biotech Products, Drugs to treat Hepatitis
Manufacturer : Beacon Pharmaceuticals Ltd.